Paclitaxel (Taxol) CAS 33069-62-4 Assay (HPLC) 97.0 ~ 102.0%
Shanghai Ruifu Chemical Co., Ltd. shine babban kamfani na Paclitaxel (Taxol) (CAS: 33069-62-4) tare da babban inganci.Ruifu Chemical na iya samar da isar da saƙo na duniya, farashi mai gasa, kyakkyawan sabis, ƙanana da adadi mai yawa akwai.Sayi Paclitaxel (Taxol),Please contact: alvin@ruifuchem.com
Sunan Sinadari | Paclitaxel |
Makamantu | Taxol;Abraxane;Genaxol;Genetaxyl;OncoGel;Pacliex;(-) Paclitaxel |
Matsayin Hannun jari | A Stock, Kasuwancin Kasuwanci |
Lambar CAS | 33069-62-4 |
Tsarin kwayoyin halitta | Saukewa: C47H51NO14 |
Nauyin Kwayoyin Halitta | 853.92 g/mol |
Matsayin narkewa | 211 ℃ (Dec.) |
Yawan yawa | 0.200 |
Ruwan Solubility | Mara narkewa a cikin Ruwa |
Solubility | Sauƙi mai narkewa a cikin Chloroform, Acetone da sauran Abubuwan Kayayyakin Halitta. |
Kwanciyar hankali | Barga.Wanda bai dace da Ƙarfafan Agents Oxidizing ba.Mai ƙonewa. |
COA & MSDS | Akwai |
Misali | Akwai |
Asalin | Shanghai, China |
Alamar | Ruifu Chemical |
Abubuwa | Ƙayyadaddun bayanai | Sakamako |
Bayyanar | Farin Crystalline Foda, Mara wari | Ya bi |
Identification (A) | IR: Concordant tare da RS | Ya bi |
Identification (B) | HPLC: RT Concordant tare da RS | Ya bi |
Takamaiman Juyawa | -49.0° zuwa -55.0° | -52.3° |
Ruwa ta Karl Fischer | ≤4.00% | 0.91% |
Ragowa akan Ignition | ≤0.20% | 0.02% |
Karfe masu nauyi (Pb) | ≤20ppm | <20ppm |
Abubuwan da ke da alaƙa | ||
Jimlar | ≤2.00% | 0.11% |
10-Deacetylbaccatin III | ≤0.10% | Ba a Gano ba |
Baccatin III | ≤0.20% | Ba a Gano ba |
Mai daukar hoto | ≤0.10% | Ba a Gano ba |
10-Deacetylpaclitaxel | ≤0.50% | 0.04% |
2-Debenzoylpaclitaxel-2-Pentenoate | ≤0.70% | Ba a Gano ba |
7- Epipaclitaxel | ≤0.40% | 0.014% |
10,13-Bissidechainpaclitaxel | ≤0.50% | 0.022% |
7-Acetylpaclitaxel | ≤0.60% | Ba a Gano ba |
13-Tes-baccatin III | ≤0.10% | 0.004% |
7-Tes-Paclitaxel | ≤0.30% | Ba a Gano ba |
Sauran Rashin Tsabtace Mutum | ≤0.10% | Ya bi |
0rganic maras kyau | Ya bi | |
Hexan | ≤290ppm | 31ppm ku |
Aceton | ≤5000ppm | 1210pm |
Assay (HPLC) | 97.0 ~ 102.0% (ƙididdigewa akan tushen anhydrous, ƙarancin ƙarfi) | 99.88% |
Gwaje-gwajen Iyakan Microbial | ||
Jimlar Ƙididdigar Ƙwayoyin Ƙirar Ƙira | ≤100 cfu/g | <100 cfu/g |
Staphylococcus Aureus | Babu | Babu |
Salmonella | Babu | Babu |
Escherichia Coli | Babu | Babu |
Bacterial Endotoxins | ≤0.4EU/mg | <0.4EU/mg |
Kammalawa | An gwada samfurin kuma ya dace da USP43 Paclitaxel |
Kunshin:Fluorinated Bottle, Aluminum tsare jakar, 25kg / Kwali Drum, ko bisa ga abokin ciniki ta bukata.
Yanayin Ajiya:Ajiye akwati sosai kuma a adana a wuri mai sanyi, bushe (2 ~ 8 ℃) da ma'ajin da ke da isasshen iska daga abubuwan da ba su dace ba.Kare daga haske da danshi.
Jirgin ruwa:Isar da shi zuwa duniya ta iska, ta FedEx / DHL Express.Bayar da isarwa cikin sauri kuma abin dogaro.
Paclitaxel
C47H51NO14 853.91
Benzenepropanoic acid, (benzoylamino) --hydroxy-, 6,12b-bis (acetyloxy) -12- (benzoyloxy) -2a,3,4,4a,5,6,9,10,11,12,12a,12b -dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4] benz [1,2-b] oxet-9-yl ester, [2aR-[2a,4,4a,6,9(R*,S*),11,12,12a,12b]]-.
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS) -1,2a,3,4,4a,6,9,10,11,12,12a,12b-Dodecahydro-4,6, 9,11,12,12b-hexahydroxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca[3,4] -benz [1,2-b] oxet-5-daya 6, 12b-diacetate, 12-benzoate, 9-ester tare da (2R,3S) -N-benzoyl-3-phenylisoserine [33069-62-4].
Paclitaxel ya ƙunshi ba kasa da kashi 97.0 ba kuma bai wuce kashi 102.0 na C47H51NO14 ba, wanda aka ƙididdige shi akan tushen anhydrous, mara ƙarfi.
[Cution-Paclitaxel shine cytotoxic.Ya kamata a kula sosai don hana shakar Paclitaxel da bayyanar da fata gare ta.]
Marufi da ajiya-Ajiye a cikin matsattsu, kwantena masu jure haske, da adanawa a yanayin zafin ɗaki mai sarrafawa.
Lakabi-Lakabin yana nuna nau'in tsari da aka yi amfani da shi don samar da kayan da gwajin mahadi masu alaƙa waɗanda kayan ya cika da su.
Matsayin Magana na USP <11>-
USP Endotoxin RS
USP Paclitaxel RS Danna don Duba Tsarin
Abubuwan da ke da alaƙa da USP Paclitaxel A RS
Cephalomannine.
Abubuwan da ke da alaƙa da USP Paclitaxel B RS
10-Deacetyl-7-Epipaclitaxel.
USP Paclitaxel Haɗin Tsabtace RS
Cakuda na Paclitaxel da mahadi masu zuwa: propyl analog, cephalomannine, sec-butyl analog, n-butyl analog, benzyl analog, baccatin VI, pentyl analog, da 7-epipaclitaxel.
Ganewa-
A: Ciwon Infrared <197K>.
B: Lokacin riƙewa na babban kololuwa a cikin chromatogram na shirye-shiryen Assay ya dace da abin da ke cikin chromatogram na daidaitaccen shiri, kamar yadda aka samu a cikin Assay.
Takamaiman jujjuyawar 781S: tsakanin 49.0 da 55.0 a 20, an ƙididdige su akan tushen rashin ƙarfi, rashin ƙarfi.
Maganin gwaji: 10 MG kowace ml, a cikin methanol.
Gwaje-gwajen ƙididdiga na ƙananan ƙwayoyin cuta <61> da Gwaje-gwaje don ƙayyadaddun ƙwayoyin cuta <62>-Jimlar ƙidayar ƙwayoyin cuta na aerobic baya wuce 100 cfu a kowace g.Ya cika ka'idodin gwaje-gwaje don rashin Staphylococcus aureus, Pseudomonas aeruginosa, nau'in Salmonella, da Escherichia coli.
Bacterial endotoxins 85-Ba ya ƙunshi fiye da 0.4 USP Endotoxin Unit da MG na paclitaxel.
Ruwa, Hanyar Ic <921>: bai wuce 4.0% ba.
Ragowa akan kunnawa <281>: bai wuce 0.2% ba.
Karfe masu nauyi, Hanyar II <231>: 0.002%.
Abubuwan da ke da alaƙa-
gwajin 1 (don kayan da aka yi wa lakabi da keɓe daga tushen halitta) - Idan kayan ya bi wannan gwajin, lakabin yana nuna cewa ya haɗu da abubuwan haɗin gwiwar USP Gwajin 1.
Diluent-Shirya kamar yadda aka umarce shi a cikin Assay.
Magani A-Shirya tacetonitrile da aka lalatar da shi.
Magani B-Shirya tacewa da kuma gurɓataccen ruwa.
Lokacin wayar hannu-Yi amfani da gauraya masu canji na Magani A da Magani B kamar yadda aka umurce su don tsarin Chromatographic.Yi gyare-gyare idan ya cancanta (duba Dacewar Tsarin ƙarƙashin Chromatography 621).
Maganin dacewa da tsarin-Narke daidai gwargwadon awo na USP Paclitaxel Related Compound A RS da USP Paclitaxel Related Compound B RS a cikin methanol don samun maganin sananniya na kusan 10 μg na kowane ml.Canja wurin 5.0 ml na wannan maganin zuwa 50-mL flask volumetric, tsarma tare da Diluent zuwa ƙara, da haɗuwa.
Standard bayani-Narke, tare da taimakon sonication, an daidai auna yawa na USP Paclitaxel RS a diluent, da kuma tsarma quantitatively, kuma stepwise idan ya cancanta, tare da diluent don samun wani bayani ciwon san maida hankali game da 5 µg da ml.
Maganin gwaji-Yi amfani da shirye-shiryen Assay.
Tsarin Chromatographic (duba Chromatography <621>) -Chromatograph na ruwa yana sanye da na'urar ganowa 227-nm da ginshiƙin 4.6-mm × 25-cm wanda ya ƙunshi 5-µm tattara L43.Matsakaicin kwarara shine kusan 2.6 ml a minti daya.Ana kiyaye zafin jiki na ginshiƙi a 30. An tsara chromatograph kamar haka.
Lokaci (minti) Magani A (%) Magani B (%) Elution
0-35 35 65 masu son kai
35–60 35®80 65®20 layin layi
60–70 80®35 20®65 layin layi
70-80 35 65 isocraticChromatograph da tsarin dacewa da tsarin, da yin rikodin martanin kololuwa kamar yadda aka tsara don Tsari: lokutan riƙewa na dangi kusan 0.78 don abubuwan da ke da alaƙa da paclitaxel A da 0.86 don fili mai alaƙa da paclitaxel B (dangane da lokacin riƙewa don paclitaxel da aka samu daga Maganin Gwaji);da ƙuduri, R, tsakanin abubuwan da ke da alaƙa da paclitaxel A da abubuwan da ke da alaƙa da paclitaxel B bai ƙasa da 1.0 ba.Chromatograph the Standard bayani, da rikodin mafi girman martani kamar yadda aka ba da umarni don Tsari: madaidaicin ma'auni don maimaita alluran bai wuce 2.0% ba.
Tsari-Alurar ƙarar (kimanin 15 µL) na maganin gwajin a cikin chromatograph, yi rikodin chromatogram, da auna wuraren don manyan kololuwa.Yi ƙididdige adadin kowane ƙazanta a cikin ɓangaren Paclitaxel da aka ɗauka ta dabara:
100 (Juma'a / rU)
a cikin abin da F shine ma'anar mayar da martani ga kowane kololuwar ƙazanta (duba Table 1 don ƙima);ri shine yanki kololuwa ga kowane rashin tsarki;kuma rU shine yanki kololuwa na paclitaxel.
Tebur 1
Dangantakar Tsayawa Lokacin Dangantakar Amsa Factor (F) Iyakar Suna (%)
0.24 1.29 Baccatin III 0.2
0.53 1.00 10-Deacetylpaclitaxel 0.5
0.57 1.00 7-Xylosylpaclitaxel 0.2
0.78 1.26 Cephalomannine (abin da ke da alaƙa da Paclitaxel A) a11
0.78 1.26 2'',3''-Dihydrocephalomannin a21
0.86 1.00 10-Deacetyl-7-epipaclitaxel (abin da ke da alaƙa da Paclitaxel B) 0.5
1.10 1.00 Benzyl analog3 b12
1.10 1.00 3'',4''-Dehydropaclitaxel C b22
1.40 1.00 7-Epicephalomannin 0.3
1.85 1.00 7-Epipaclitaxel 0.5
1 Ƙidumar ƙila ba ta cika ga waɗannan kololuwa ba, ya danganta da adadin dangi;jimlar a1 da a2 bai wuce 0.5% ba.
2 Ƙidumar ƙila ba ta cika ga waɗannan kololuwa ba, ya danganta da adadin dangi;jimlar b1 da b2 bai wuce 0.5% ba.
3 Ana sanya sunan sinadarai mai zuwa ga mahaɗin da ke da alaƙa, analogin benzyl: Baccatin III 13-ester tare da (2R,3S) -2-hydroxy-3-phenyl-3- (2-phenylacetylamino) propanoic acid.
Bugu da ƙari, rashin ƙetare iyaka don ƙazantattun abubuwan da suka shafi paclitaxel a cikin Table 1, ba a sami fiye da 0.1% na kowane ƙazanta ɗaya ba;kuma ba fiye da 2.0% na jimlar ƙazanta ana samun su ba.
gwajin 2 (don kayan da aka lakafta kamar yadda aka samar ta hanyar tsarin semisynthetic) - Idan kayan ya bi wannan gwajin, lakabin yana nuna cewa ya haɗu da abubuwan haɗin gwiwar USP Gwajin 2.
Diluent-Yi amfani da acetonitrile.
Magani A-Yi amfani da cakudaccen ruwa da aka tace da kuma acetonitrile (3:2).
Magani B-Yi amfani da tacewa da kuma lalata acetonitrile.
Lokacin wayar hannu-Yi amfani da gauraya masu canji na Magani A da Magani B kamar yadda aka umurce su don tsarin Chromatographic.Yi gyare-gyare idan ya cancanta (duba Dacewar Tsarin ƙarƙashin Chromatography 621).
Maganin dacewa da tsarin-Narke daidai adadin USP Paclitaxel RS da USP Paclitaxel Related Compound B RS a cikin Diluent, girgiza da sonicating idan ya cancanta, don samun maganin da aka sani game da 0.96 MG da 0.008 MG kowace ml, bi da bi.
Magani na gwaji-Canja wurin kusan 10 MG na Paclitaxel, daidai aunawa, zuwa flask volumetric na 10-mL, narkar da kuma tsarma tare da Diluent zuwa girma, girgiza da sonicating idan ya cancanta, da haɗuwa.
Tsarin Chromatographic (duba Chromatography 621) - Na'urar chromatograph na ruwa an sanye shi da na'urar ganowa 227-nm da ginshiƙin 4.6-mm × 15-cm wanda ya ƙunshi 3-µm tattara L1.Matsakaicin kwarara shine kusan 1.2 ml a minti daya.Ana kiyaye zafin jiki na ginshiƙi a 35. An tsara chromatograph kamar haka.
Lokaci (minti) Magani A (%) Magani B (%) Elution
0-20 100 0 masu zaman kansu
20-60 100®10 0®90 layin layi
60-62 10®100 90®0 layin layi
62-70 100 0 isocraticChromatograph da tsarin dacewa da tsarin, da kuma rikodin mafi girman martani kamar yadda aka tsara don Tsari: lokutan riƙewa na dangi kusan 0.94 don fili mai alaƙa da paclitaxel B da 1.0 don paclitaxel;ƙuduri, R, tsakanin abubuwan da ke da alaƙa da paclitaxel B da paclitaxel bai kasance ƙasa da 1.2 ba;kuma madaidaicin ma'auni na dangi don kwafin injections bai wuce 2.0%.
Tsari-Na dabam allura daidai juzu'i (kimanin 15 µL) na Diluent da Maganin Gwaji a cikin chromatograph, yi rikodin chromatograms, da auna wuraren ga duk kololuwa.Yi watsi da kowane kololuwa saboda Diluent.Yi ƙididdige adadin kowane ƙazanta a cikin ɓangaren Paclitaxel da aka ɗauka ta dabara:
100 (Juma'a / s)
a cikin abin da F shine ma'anar amsawa ga kowane ƙazanta (duba Table 2 don dabi'u);ri shine yanki kololuwa ga kowane kazanta da aka samu daga maganin gwajin;kuma rs shine jimlar wuraren duk kololuwar da aka samu daga maganin gwajin.
Table 2
Dangantakar Tsayawa Lokacin Dangantakar Amsa Factor (F) Iyakar Suna (%)
0.11 1.24 10-Deacetylbaccatin III 0.1
0.20 1.29 Baccatin III 0.2
0.42 1.39 Photodegradant2 0.1
0.47 1.00 10-Deacetylpaclitaxel 0.5
0.80 1.00 2-Debenzoylpaclitaxel-2-pentenoate 0.7
0.921 1.00 Oxetane da aka buɗe, acetyl da benzoyl sun yi ƙaura2 x1
0.921 1.00 10-Acetoacetylpaclitaxel x2
0.941 1.00 10-Deacetyl-7-epipaclitaxel (abin da ke da alaƙa da Paclitaxel B) x3
1.37 1.00 7-Epipaclitaxel 0.4
1.45 1.00 10,13-Bissidechainpaclitaxel2 0.5
1.54 1.00 7-Acetylpaclitaxel 0.6
1.80 1.75 13-Tes-baccatin III 0.1
2.14 1.00 7-Tes-paclitaxel 0.3
1 Ƙidumar ƙila ba ta cika ga waɗannan kololuwa ba, ya danganta da adadin dangi;jimlar x1, x2, da x3 bai wuce 0.4% ba.
2 Ana sanya sunayen sunadarai masu zuwa ga mahaɗan da ke da alaƙa Photodegradant;Oxetane zobe ya buɗe, acetyl da benzoyl sun yi hijira;da 10,13-Bissidechainpaclitaxel:
Mai daukar hoto
(1R,2R,4S,5S,7R,10S,11R,12S,13S,15S,16S)-2,10-diacetyloxy-5,13-dihydroxy-4,16,17,17-tetramethyl-8-oxa- 3-oxo-12-phenylcarbonyloxypentacyclo [11.3.1.01,11.04,11.07,10] heptadec-15-yl
(2R, 3S) -2-hydroxy-3-phenyl-3- (phenylcarbonylamino) propanoate
Oxetane zobe ya buɗe, acetyl da benzoyl sunyi ƙaura
(1S,2S,3R,4S,5S,7S,8S,10R,13S)-5,10-diacetyloxy-1,2,4,7-tetrahydroxy-8,12,15,15-tetramethyl-9-oxo- 4- (phenylcarbonyloxymethyl) tricyclo[9.3.1.03,8] pentadec-11-en-13-yl
(2R, 3S) -2-hydroxy-3-phenyl-3- (phenylcarbonylamino) propanoate
10,13-Bissidechainpaclitaxel
Baccatin III 13-ester tare da (2R,3S) -2-hydroxy-3-phenyl-3- (phenylcarbonylamino) propanoic acid, 10-ester tare da (2S,3S) -2-hydroxy-3-phenyl-3- (phenylcarbonylamino). Propanoic acid
Bugu da ƙari, rashin ƙetare iyaka ga ƙazantattun abubuwan da ke da alaƙa da paclitaxel a cikin Table 2, ba a sami fiye da 0.1% na kowane ƙazanta ɗaya ba;kuma ba fiye da 2.0% na jimlar ƙazanta ana samun su ba.
gwajin 3 (don kayan da aka lakafta kamar yadda aka samar ta hanyar tsarin haifuwa ta kwayar halitta) - Idan kayan ya bi wannan gwajin, lakabin yana nuna cewa ya dace da abubuwan da ke da alaƙa da USP Gwajin 3.
Magani A-Shirya tsaftataccen ruwan da aka lalatar da ruwa da acetonitrile (3:2).
Magani B-Shirya tacewa da kuma lalata acetonitrile.
Lokacin wayar hannu-Yi amfani da gauraya masu canji na Magani A da Magani B kamar yadda aka umurce su don tsarin Chromatographic.Yi gyare-gyare idan ya cancanta (duba Dacewar Tsarin ƙarƙashin Chromatography 621).
Maganin dacewa da tsarin-Narke USP Paclitaxel Rashin Tsabtace Cakuda RS a cikin acetonitrile, sonicating idan ya cancanta, don samun maganin ciwon sananniya na kusan 1 MG kowace ml.
Daidaitaccen bayani-Narke adadin USP Paclitaxel RS daidai gwargwado a cikin acetonitrile, sonicating idan ya cancanta, don samun maganin ciwon sananniya na kusan 1 MG kowace ml.
Maganin gwajin gwaji-Canja wurin kusan MG 10 na Paclitaxel, daidaitaccen auna, zuwa faifan girma na 10-ml.Narkar da kuma tsoma tare da acetonitrile zuwa girma, sonicating idan ya cancanta, da haɗuwa.
Tsarin Chromatographic (duba Chromatography 621) - Na'urar chromatograph na ruwa an sanye shi da na'urar ganowa 227-nm da ginshiƙin 4.6-mm × 15-cm wanda ya ƙunshi 3-µm tattara L1.Matsakaicin kwarara shine kusan 1.2 ml a minti daya.An tsara chromatograph kamar haka.
Lokaci (minti) Magani A (%) Magani B (%) Elution
0-28 100 0 masu zaman kansu
28-33 100®98 0®2 layin layi
33–58 98®10 2®90 layin layi
58-60 10 90 masu bautar gumaka
60-63 10®100 90®0 layin layi
63-70 100 0 isocraticChromatograph da tsarin dacewa da tsarin, da rikodin mafi girman martani kamar yadda aka tsara don Tsari: ƙuduri, R, tsakanin paclitaxel da analog na benzyl bai ƙasa da 1.8 ba.Chromatograph the Standard bayani, da rikodin mafi girman martani kamar yadda aka ba da umarni don Tsari: madaidaicin ma'auni don maimaita alluran bai wuce 2.0% ba.[bayanin kula-Don manufar gano kololuwa, ana ba da kusan lokutan riƙewa na dangi a cikin Teburin 3. An auna lokutan riƙewar dangi tare da Paclitaxel.]
Table 3
Iyakacin Lokacin Riƙe Sunan (%)
Analog na Propyl 1 0.54 0.2
Cephalomannine (Magungunan da ke da alaƙa da Paclitaxel A) 0.76 0.5
sec-Butyl analog2 0.81 0.2
n-Butyl analog3 0.89 0.1
Benzyl analog 1.10 0.4
Baccatin VI 1.23 0.2
Pentyl analog 1.31 0.2
7-Epipaclitaxel 1.51 0.4
1 Ana sanya sunan sinadarai mai zuwa ga abin da ke da alaƙa Propyl analog:Baccatin III 13-ester tare da (2R,3S) -3-butanoylamino-2-hydroxy-3-phenylpropanoic acid.
2 Ana sanya sunan sinadarai mai zuwa ga mahaɗin da ke da alaƙa sec-Butyl analog:Baccatin III 13-ester tare da (2R,3S) -2-hydroxy-3- (2-methylbutanoylamino) -3-phenylpropanoic acid.
3 Sunan sinadarai mai zuwa an sanya shi zuwa wani abu mai alaƙa n-Butyl analog:Baccatin III 13-ester tare da (2S,3S) -2-hydroxy-3-(pentanoylamino) -3-phenylpropanoic acid.
4 Ana sanya sunan sinadarai mai zuwa ga abin da ke da alaƙa Pentyl analog: Baccatin III 13-ester tare da (2R,3S) -3-(hexanoylamino) -2-hydroxy-3-phenylpropanoic acid.
Tsari - Allurar ƙarar (kimanin 12 µL) na maganin gwajin a cikin chromatograph, yi rikodin chromatogram, da auna wuraren don duk kololuwa.Yi ƙididdige adadin kowane ƙazanta a cikin ɓangaren Paclitaxel da aka ɗauka ta dabara:
100 (ri / rU)
wanda ri ne martanin kowane mutum da kazanta;kuma rU shine jimlar wuraren duk kololuwar da aka samu daga maganin gwajin.Bugu da ƙari, rashin ƙetare iyaka don ƙazantattun abubuwan da ke da alaƙa da paclitaxel a cikin Table 3, ba a sami fiye da 0.1% na kowane ƙazanta ɗaya ba;kuma ba fiye da 2.0% na jimlar ƙazanta ana samun su ba.
Assay-
Diluent-Shirya cakuda methanol da acetic acid (200: 1).
Wayar hannu lokaci-Shirya taceccen ruwa mai tsaftataccen ruwa da acetonitrile (11:9).Yi gyare-gyare idan ya cancanta (duba Dacewar Tsarin ƙarƙashin Chromatography 621).
Standard shirye-shirye-Narke, ta yin amfani da sonication idan ya cancanta, an daidai auna adadin USP Paclitaxel RS a diluent, da kuma tsarma quantitatively, kuma stepwise idan ya cancanta, tare da diluent don samun wani bayani ciwon san maida hankali game da 1 MG da ml.
Shirye-shiryen Assay-Canja wurin kusan MG 10 na Paclitaxel, daidaitaccen auna, zuwa flask mai girma na 10-ml.Narke a cikin Diluent, ta amfani da sonication idan ya cancanta, tsoma tare da Diluent zuwa girma, da kuma haɗuwa.
Tsarin Chromatographic (duba Chromatography <621>) -Chromatograph na ruwa yana sanye da na'urar ganowa 227-nm da ginshiƙin 4.6-mm × 25-cm wanda ya ƙunshi 5-µm tattara L43.Matsakaicin kwarara shine kusan 1.5 ml a minti daya.Chromatograph da Daidaitaccen shiri, da rikodin mafi girman martani kamar yadda aka ba da umarni don Tsari: ma'aunin wutsiya yana tsakanin 0.7 da 1.3;kuma madaidaicin ma'auni na dangi don kwafin injections bai wuce 1.5%.
Tsari-Na dabam allura daidai juzu'i (kimanin 10 µL) na daidaitaccen shiri da shirye-shiryen Assay a cikin chromatograph, yi rikodin chromatograms, da auna wuraren don manyan kololuwa.Yi ƙididdige adadin, a cikin MG, na C47H51NO14 a cikin ɓangaren Paclitaxel da aka ɗauka ta dabara:
10C (rU / rS)
wanda C shine maida hankali, a cikin MG da ml, na USP Paclitaxel RS a cikin Shirye-shiryen Standard;da rU da rS sune mafi girman martani ga paclitaxel da aka samu daga shirye-shiryen Assay da Daidaitaccen shiri, bi da bi.
Yadda ake siya?Da fatan za a tuntuɓiDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
Kwarewar Shekaru 15?Muna da fiye da shekaru 15 na gwaninta a cikin ƙira da fitarwa na matsakaicin matsakaicin magunguna masu inganci ko sinadarai masu kyau.
Manyan Kasuwanni?Sayarwa zuwa kasuwannin cikin gida, Arewacin Amurka, Turai, Indiya, Koriya, Jafananci, Australia, da sauransu.
Fa'idodi?Babban inganci, farashi mai araha, sabis na ƙwararru da tallafin fasaha, bayarwa da sauri.
inganciTabbaci?Tsananin kula da ingancin inganci.Kayan aikin ƙwararru don bincike sun haɗa da NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, gwajin ƙayyadaddun ƙwayoyin cuta, da sauransu.
Misali?Yawancin samfurori suna ba da samfurori kyauta don ƙima mai kyau, farashin jigilar kaya ya kamata a biya ta abokan ciniki.
Binciken Masana'antu?Ma'aikata duba maraba.Da fatan za a yi alƙawari a gaba.
MOQ?Babu MOQ.Karamin tsari abin karɓa ne.
Lokacin Bayarwa? Idan cikin hannun jari, garantin isar da kwana uku.
Sufuri?By Express (FedEx, DHL), ta Air, ta Teku.
Takardu?Bayan sabis na tallace-tallace: COA, MOA, ROS, MSDS, da dai sauransu za a iya ba da su.
Haɗin Kan Al'ada?Zai iya ba da sabis na haɗawa na al'ada don dacewa da buƙatun bincikenku.
Sharuɗɗan Biyan kuɗi?Za a fara aiko da daftari na Proforma bayan tabbatar da oda, an rufe bayanan bankin mu.Biya ta T/T (Telex Transfer), PayPal, Western Union, da dai sauransu.
Alamomin haɗari Xn - Cuta
Lambobin haɗari R37/38 - Haushi ga tsarin numfashi da fata.
R41 - Hadarin mummunan lalacewa ga idanu
R42/43 - Yana iya haifar da hankali ta hanyar shakar numfashi da tuntuɓar fata.
R62 - Haɗari mai yuwuwar rashin haihuwa
R68 - Haɗarin da ba za a iya jurewa ba
R40 - Shaida mai iyaka na tasirin cutar sankara
R48 - Haɗarin mummunan lahani ga lafiya ta hanyar ɗaukar dogon lokaci
R20/21/22 - Cutarwa ta hanyar shakarwa, a cikin hulɗa da fata kuma idan an haɗiye shi.
R68/20/21/22 -
Bayanin Tsaro S22 - Kar a shaka ƙura.
S26 - Idan ana hulɗa da idanu, kurkura nan da nan da ruwa mai yawa kuma ku nemi shawarar likita.
S36/37/39 - Sanya tufafin kariya masu dacewa, safar hannu da kariya ta ido/ fuska.
S45 - Idan akwai haɗari ko kuma idan kun ji rashin lafiya, nemi shawarar likita nan da nan (nuna alamar a duk lokacin da zai yiwu.)
Bayanan Bayani na UN1544
WGK Jamus 3
RTECS DA8340700
FLUKA BRAND F CODES 10-21
HS Code 2932999021
Matsayin Hazard 6.1(b)
Rukunin tattarawa na III
Guba LD50 intraperitoneal a cikin linzamin kwamfuta: 128mg/kg
Paclitaxel (Taxol) (CAS: 33069-62-4), wani samfurin halitta wanda aka keɓe daga haushi na yew na Pacific, yana da tasiri wajen magance ciwon daji na ovarian metastatic.Ba kamar sauran magungunan antineoplastic ba, paclitaxel ya bayyana yana da hanyoyin da za a iya aiwatar da su, ciki har da aikin antimicrotubule ta hanyar inganta tubulin polymerization da kuma daidaitawar microtubules, ta haka, dakatar da mitosis da inganta mutuwar kwayar halitta.Samar da paclitaxel yana iyakance ne ta ƙarancin wadatar halitta kuma a halin yanzu ana kera shi ta hanyar sinadari mai sinadari daga deacetylbaccatin Ⅲ wanda ke ware daga alluran itacen yew.Kammala kwanan nan na jimlar duka biyu na taxol ya ci nasara kan tsarin ginin fili kuma yana iya zama da amfani wajen samun wasu analogs masu alaƙa, waɗanda aka gano wasu daga cikinsu suna da aikin antitumor.Paclitaxel yana da yuwuwar amfani da shi a cikin maganin cutar kansar nono metastatic, kansar huhu, kansa da wuyansa, da kuma melanoma mara kyau.
Sinadaran masu guba a cikin rassa da ganyen Taxus chinensis an raba su a cikin 1856 kuma an sanya musu suna “taxine,” wanda aka gano a matsayin wani nau’in sinadarin farin alkaloid.A halin yanzu, a cikin dukkanin magungunan antitumor, siyar da paclitaxel ya zama na farko a duniya a matsayin sanannen maganin ciwon daji tare da aiki mai girma.A watan Oktoba na shekarar 1995, kasar Sin ta zama kasa ta biyu da ke samar da paclitaxel a hukumance da allurarsa a duniya.An samu nasarar ne a karkashin yunƙurin da masu bincike suka yi a Cibiyar Nazarin Materia Medica, Cibiyar Nazarin Kiwon Lafiya ta kasar Sin.
Paclitaxel (CAS: 33069-62-4) wani maganin antineoplastic ne wanda ake amfani dashi don kula da marasa lafiya masu fama da huhu, ovarian, ciwon nono, ciwon kai da wuyansa, da kuma nau'i na sarcoma na Kaposi.Paclitaxel shine mai hana mitotic da ake amfani dashi a cikin chemotherapy.Hakanan ana amfani dashi a cikin nazarin tsari da aikin microtubles cikin tubulin.
Paclitaxel yana da tasiri mai kyau akan ciwon daji na ovarian refractory da ciwon nono tare da juriya na miyagun ƙwayoyi irin su ciwon daji na ovarian da platinum, da kuma kyakkyawan fata don maganin ciwon daji na prostate, ciwon kai da wuyansa, ciwon daji na esophageal, ƙwayar ƙwayar ƙwayar cuta, ciwon daji na endometrial, lymphoma, ciwon daji na mafitsara, ciwon daji na hanji na sama, ƙananan ƙwayoyin cuta da kuma ciwon huhu marasa ƙananan ƙwayoyin cuta.
Paclitaxel (Taxol) (CAS: 33069-62-4) wani hadadden abu ne mai matukar rikitarwa, sinadari na halitta wanda aka ware daga bawon itacen yew na Pacific.Yana ɗaure zuwa tubulin dimers da microtubulin filaments, inganta taro na filaments da kuma hana su depolymerization.Wannan karuwa a cikin kwanciyar hankali na microfilaments yana haifar da rushewar mitosis da cytotoxicity kuma ya rushe sauran ayyukan microtubular na al'ada, irin su jigilar axonal a cikin filaye na jijiya.Babban tsarin juriya da aka gano don paclitaxel shine jigilar kaya daga ƙwayoyin tumo, wanda ke haifar da raguwar ƙwayar ƙwayar ƙwayar ƙwayar cuta.Wannan nau'i na juriya yana yin sulhu ta hanyar jigilar magunguna da yawa P-glycoprotein.
Zai iya zama mai kula da tsayin daka ga danshi.